Stratec SE (ETR:SBS – Get Free Report)’s stock price traded up 0.4% during trading on Friday . The stock traded as high as €23.30 and last traded at €23.00. 5,227 shares traded hands during trading, a decline of 16% from the average session volume of 6,253 shares. The stock had previously closed at €22.90.
Stratec Stock Performance
The stock’s 50-day moving average is €22.28 and its 200-day moving average is €25.36. The stock has a market cap of $276.32 million, a price-to-earnings ratio of 27.60, a P/E/G ratio of 10.43 and a beta of 0.16. The company has a current ratio of 2.52, a quick ratio of 1.65 and a debt-to-equity ratio of 66.97.
Stratec Company Profile
Stratec SE, together with its subsidiaries, designs and manufactures automation and instrumentation solutions in the fields of in-vitro diagnostics and life sciences in Germany, European Union, and internationally. It designs and manufactures automated analyzer systems for clinical diagnostics and biotechnology customers; and offers complex consumables for diagnostics and medical applications. The company was formerly known as STRATEC Biomedical AG and changed its name to Stratec SE in December 2018.
See Also
- Five stocks we like better than Stratec
- How a Family Trust May Be Able To Help Preserve Your Wealth
- Do not delete, read immediately
- Your Signature Is Missing – Act Before It’s Too Late
- The $100 Trillion AI Story No One Is Telling You
- NEW LAW: Congress Approves Setup For Digital Dollar?
Receive News & Ratings for Stratec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stratec and related companies with MarketBeat.com's FREE daily email newsletter.
